OKUR
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
OKUR
51 hedge funds and large institutions have $99.2M invested in OnKure Therapeutics, Inc. Class A Common Stock in 2024 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 20 increasing their positions, 10 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
–
Holders Change %
0%
% of All Funds
0.68%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
20
Increased
20
Reduced
10
Closed
19
Calls
$243K
Puts
–
Net Calls
+$243K
Net Calls Change
+$140K
Top Buyers
1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$15.8M |
2 |
Citadel Advisors
Miami,
Florida
|
+$8.71M |
3 |
PA
Perceptive Advisors
New York
|
+$8.64M |
4 |
SB
Samsara BioCapital
Palo Alto,
California
|
+$7.09M |
5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.32M |
Top Sellers
1 |
BCM
BML Capital Management
Zionsville,
Indiana
|
-$5.88M |
2 |
OCA
Octagon Capital Advisors
New York
|
-$3.83M |
3 |
AI
Acuitas Investments
Seattle,
Washington
|
-$685K |
4 |
Two Sigma Investments
New York
|
-$230K |
5 |
JC
JBF Capital
Aspen,
Colorado
|
-$136K |